No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Adaptimmune Says CFO, Other C-Suite Officer to Step Down
Adaptimmune: Focusing Increasing Proportion of Corporate Functions in U.S. >ADAP
Express News | Adaptimmune Therapeutics PLC - Gavin Wood to Step Down as Chief Financial Officer
First Patient Treated With Adaptimmune's TECELRA(R) (Afamitresgene Autoleucel)
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading
Express News | Adaptimmune Therapeutics PLC : Mizuho Cuts Target Price to $1.50 From $3